Evidence map›Paper›PMID 27629384›Full record

ArticleJournal of thrombosis and haemostasis : JTH2016

Combined variants in factor VIII and prostaglandin synthase-1 amplify hemorrhage severity across three generations of descendants.

D Nance, R A Campbell, J W Rowley, J M Downie, L B Jorde, W H Kahr, S A Mereby, N D Tolley, G A Zimmerman, A S Weyrich and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

D NanceThe Division of Hematology, University of Utah, Salt Lake City, UT, USA.
R A CampbellMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
J W RowleyMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
J M DownieDepartment of Human Genetics, University of Utah, Salt Lake City, UT, USA.
L B JordeDepartment of Human Genetics, University of Utah, Salt Lake City, UT, USA.
W H KahrDepartment of Paediatrics, Division of Haematology/Oncology, University of Toronto, Toronto, ON, Canada.
S A MerebyMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
N D TolleyMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
G A ZimmermanDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
A S WeyrichMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
M T RondinaMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
University of Utah · USGeorge E. Wahlen Department of VA Medical Center · USUniversity of Toronto · CA

Funding

Translational Research Skills Development CoreU54HL112311 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S · 2012 to 2016
$12.9M
TRANSLATIONAL EVENTS IN PLATELETSR01HL066277 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S · 2001 to 2012
$3.8M
The Effects of ART on Platelets and HIV-Associated ThrombosisR01HL126547 · NHLBI · UNIVERSITY OF UTAH · PI PLANELLES, VICENTE, RONDINA, MATTHEW THOMAS · 2014 to 2017
$3.0M
The Platelet Metabolome in ObesityK01GM103806 · NIGMS · UNIVERSITY OF UTAH · PI ROWLEY, JESSE · 2012 to 2016
$802k
Novel Platelet Functions in Sepsis and Venous ThromboembolismK23HL092161 · NHLBI · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2009 to 2013
$775k
The Regulation of Inflammatory Gene Responses in AgingR03AG040631 · NIA · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2011 to 2012
$149k
CIHR MOP-259952CIHR MOP-81208NHLBI NIH HHS K23 HL092161NHLBI NIH HHS R01 HL066277NHLBI NIH HHS R01 HL126547NHLBI NIH HHS U54 HL112311NIA NIH HHS R03 AG040631NIGMS NIH HHS K01 GM103806
6 · The paper itself

Abstract

Essentials Co-existent damaging variants are likely to cause more severe bleeding and may go undiagnosed. We determined pathogenic variants in a three-generational pedigree with excessive bleeding. Bleeding occurred with concurrent variants in prostaglandin synthase-1 (PTGS-1) and factor VIII. The PTGS-1 variant was associated with functional defects in the arachidonic acid pathway. SUMMARY: Background Inherited human variants that concurrently cause disorders of primary hemostasis and coagulation are uncommon. Nevertheless, rare cases of co-existent damaging variants are likely to cause more severe bleeding and may go undiagnosed. Objective We prospectively sought to determine pathogenic variants in a three-generational pedigree with excessive bleeding. Patients/methods Platelet number, size and light transmission aggregometry to multiple agonists were evaluated in pedigree members. Transmission electron microscopy determined platelet morphology and granule content. Thromboxane release studies and light transmission aggregometry in the presence or absence of prostaglandin G

Indexed as

AdultAgedArachidonic AcidChildCyclooxygenase 1Factor VIIIFamily HealthFemaleGene FrequencyGenetic VariationHemorrhageHumansMaleMiddle AgedPedigreePlatelet AggregationArachidonic AcidCyclooxygenase 1F8 protein, humanFactor VIIIProstaglandin-Endoperoxide SynthasesPTGS1 protein, humanThromboxane B2bleedingblood platelet disorderDNA sequencinghemophilia Aplatelet aggregation

Identifiers

PMID27629384
PMCPMC5501291
OpenAlexW2519670344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.